High mammographic density is a strong breast cancer risk factor. Density normally declines with aging. We investigated whether the level of decline in mammographic density is related to breast cancer risk using a nested case-control study within the European Prospective Investigation into Cancer and Nutrition (EPIC)-Prospect cohort. This cohort was recruited among participants of a population-based breast cancer screening program in the Netherlands between 1993 and 1997. We examined whether age-related changes in mammographic density were different for 533 cases and 1,367 controls who were 49-69 years of age at the time of recruitment into the cohort. We used mixed models with linear and quadratic terms for age and interaction terms between age terms and case status. The percent mammographic density at the first available mammogram was higher for cases than for controls (25.2% vs. 22.5%) (P = 0.003). The average decline in density over 10 years was 11% in both cases and controls (P = 0.56). When studying changes among 4 categories of density, we saw some indication that large changes may influence breast cancer risk. Although no difference was seen in the average decline, we cannot exclude that large changes may influence breast cancer risk.
For several decades, it has been known that high mammographic density, representing a high amount of epithelial and stromal tissue in the breast, is one of the strongest independent risk factors for breast cancer (1, 2) . Still, the biological mechanism of the increased risk in women with high mammographic density is poorly understood (3) . Breast cancer rises from the epithelial cells, and one explanation could simply be that the larger number of epithelial cells increases the chance of one or more cells undergoing malignant transformation. The finding that significantly more tumors arise in the dense than the nondense tissue is supportive of a direct causal effect, rather than mammographic density's being merely a marker of risk (4, 5) .
The majority of studies investigating the association between mammographic density and breast cancer risk have been based on a single mammographic examination per woman, taken between 1 and 16 years before the breast cancer diagnosis (1, 6) . A few studies evaluated density changes in relation to breast cancer risk. Some did not observe a relation between changes in density and breast cancer risk (7, 8) , whereas others did find a decreased risk with diminishing mammographic density and higher risk with an increase in mammographic density (9) (10) (11) . To investigate this further, we examined whether the change in mammographic density was related to the risk of breast cancer in a large nested casecontrol study of women with at least 3 and up to 11 mammograms. For comparability with previous studies, we studied changes on both a continuous scale and between categories of mammographic density. We hypothesize that, in women with reduced loss of mammographic density after the age of 50 years, subsequent breast cancer risk is increased.
MATERIALS AND METHODS

Study setting and population
The study population comprises participants of the European Prospective Investigation into Cancer and Nutrition (EPIC)-Prospect study (12) (13) (14) (15) . They (n = 17,357) were recruited through the breast cancer screening program in Utrecht and vicinity between 1993 and 1997 and were aged 49-70 years at that time. At the time of recruitment, the participants filled out extensive questionnaires on demographic, lifestyle, and reproductive factors, as well as past and current morbidity, and anthropometric parameters were measured. Participants further filled out 2 follow-up questionnaires with time intervals of 3-5 years in order to measure changes in risk factors.
Incident breast cancer cases were identified by linking the cohort data with the national cancer registry. Until 2008, 831 breast cancer cases were identified. For each breast cancer case, 3 controls were selected from the cohort by using incidence density sampling (16) . In total, 2,493 controls were selected. Breast cancer cases and controls were excluded if they previously had a diagnosis of any type of cancer, except nonmelanoma skin cancer. To be able to consider nonlinear changes in mammographic density, we included only women who had at least 3 mammographic examinations available. Finally, women with breast implants were excluded from the analysis. If a case was excluded, the respective controls were also excluded. In total, 533 breast cancer cases and 1,367 controls were eligible for this study ( Figure 1 ).
All participants signed informed consent, and the study was approved by the institutional review board.
Mammographic density assessment
Mammograms were all obtained at the biennial populationbased breast cancer screening program. Mammographic density was assessed by using the left mediolateral oblique mammogram. All available mammograms of a woman taken between 1989 and 2007 were collected (i.e., 10,695 mammograms, belonging to 533 cases and 1,367 controls). Over 99% of the mammograms were film-screen mammograms. They were digitized with a Canon CFS300 scanner (R2 Technology, Grand Rapids, Michigan) with a pixel resolution of 50 μm and 12 bits per pixel (optical density throughout the diagnostic range, 0-3.5). The remaining full-field digital mammograms (n = 93) were processed to make them look similar to the digitized film-screen mammograms as we have described before (17) . For breast cancer cases, only screening mammograms taken until breast cancer diagnosis were used to measure mammographic density. For controls, we used the mammograms that were taken before the corresponding case developed breast cancer.
Cumulus software (University of Toronto, Toronto, Canada) was used to assess mammographic density as described in an earlier study (18) . All serial mammograms of a case and its corresponding controls were in the same batch but randomly ordered (19) . The intraclass correlation coefficients for the within-batch correlation, as well as the between-batch correlation, were 0.98, 0.98, and 1.00 for percent density, dense area, and breast size, respectively.
Potential confounders
For potential confounders that change over time, information collected from different time points was used for the analysis. Body mass index was measured at recruitment and calculated from baseline height and self-reported weight from a follow-up questionnaire approximately 3-5 years after recruitment. With these data, we created a body mass index variable for each mammogram. For mammograms taken before or at recruitment, we used body mass index at recruitment and, for mammograms taken at or after the first follow-up (3-5 years), body mass index at the follow up measurement was used. For mammograms taken in between, we used the mean of the 2 measurements. Menopausal status at each mammographic examination was estimated from the age at menopause that was reported at recruitment and at follow-up. Women were classified as postmenopausal if they reported absence of menstrual cycles in the previous 12 months. Information about starting and stopping of hormone therapy was also available in the questionnaires. Women with a mammogram taken in the period between the start and stop age were classified as "current users" for that mammogram. Women with a mammogram taken after the age of stopping were classified as "past users" and with a mammogram before the starting age as "never users" for that mammogram. Contraceptive pill use at each mammographic examination was assessed in the same way.
Statistical analysis
Patient characteristics were described for cases and controls. For continuous variables, we used means with standard deviations if normally distributed and medians with interquartile ranges for skewed data. For categorical variables, we show proportions. We used linear mixed models to examine whether changes in mammographic density over time differ between cases and controls while taking the clustering of measurements into account. Subjects with ≥3 mammograms were included in the mixed models. The dependent variable consisted of repeated readings of mammographic density ( percent density and dense area). Fixed effects were age at mammography (centered on the mean) and breast cancer status; an interaction term between age at mammography and breast cancer status was included to assess whether changes in mammographic density with age differed between breast cancer cases and controls. Age at mammography was modeled with both linear and quadratic terms, as mammographic density is expected to decline more steeply around menopause and more slowly thereafter. A random intercept and a random slope for age were included in the models. The differences in changes with age between cases and controls were tested by assessing whether the models with and without the linear and quadratic interaction terms differed significantly when a likelihood ratio test was used.
Body mass index, height, parity, age at first delivery, number of children, menopausal status, contraceptive pill use, and hormone therapy use were included as fixed effects in the model, to adjust for potential confounding. Body mass index, menopausal status, contraceptive pill use, and hormone therapy use were analyzed as time-dependent covariates as they could change over time (level 1). In a sensitivity analysis for absolute dense area, body mass index was replaced by absolute nondense area because we observed in earlier research that adjusting the absolute dense area for absolute nondense area instead of body mass index might give more valid results (18) . The risk factors parity, age at first delivery (categorized as no children, first delivery at <25 years, first delivery at ≥25 years), number of children, and height were included as fixed variables (level 2) in the model.
We also analyzed the effect of large between-category changes. We used density measurements of the first (initial) and last available mammograms of each woman. Percent density was divided into <5%, 5%-25%, >25%-50%, and >50% density. Dense area was divided into quartiles on the basis of the distribution of dense area on the controls' first available mammograms. Next, study participants were categorized according to stable, declining, or increasing density over a period of 10 years. Logistic regression analyses were performed to estimate breast cancer risk comparing women who declined or increased in density with women who stayed in the same category (reference). All logistic regression analyses were adjusted for the same potential confounders as the linear mixed effects model, plus the follow-up time between the first and last mammograms.
Because of a large number of missing values in age at menarche and family history, these variables were not included in any model. We conducted a sensitivity analysis among women for whom these variables were available to examine the effect of adding these variables to the fully adjusted models. Furthermore, a sensitivity analysis was performed excluding the mammogram taken within 1 year before the breast cancer diagnosis. The reason was that tumor tissue has the same radiological attenuation as the fibroglandular tissue, and therefore the density based on this mammogram could be higher because of the presence of a tumor. Finally, a sensitivity analysis was performed excluding digital mammograms, because the amount of dense tissue displayed on digital and film-screen mammograms might be different because of the differences in techniques. To test if the sensitivity analyses changed the results, likelihood ratio tests were performed.
All P values are 2 sided and, if P < 0.05, results were considered statistically significant. Longitudinal analyses were performed by using the CRAN packages LME and lattice of R, version 2.9.2, statistical software (R Foundation for Statistical Computing, Vienna, Austria). Other analyses were conducted by using PASW Statistics 17.0 (SPSS, Inc., Chicago, Illinois). Table 1 presents the characteristics of the breast cancer cases and controls. Breast cancer cases are more likely to have a first-degree relative who has had breast cancer (P = 0.001). Furthermore, breast cancer cases are older at the initial mammogram, slightly older at the first full-term pregnancy, more often nulliparous, and more likely to have used hormone therapy, and they have a slightly higher body mass index, although these differences were not statistically significant.
RESULTS
The mean percent density at the initial mammogram was 25.2% for breast cancer cases versus 22.5% for controls (P = 0.003). The absolute dense area was also higher in breast cancer cases than in controls (34. years for controls. At the last available mammographic examination, the percent density was 14.4% for breast cancer cases and 12.0% for controls (P < 0.001). The mean decline in percent density between the first and last available mammograms was 10.8% for both breast cancer cases and controls (P = 0.99) ( Table 2) . Table 3 summarizes the mixed-model estimates of the relation between changes in mammographic density and breast cancer status. Breast cancer cases had a 1.42% (P < 0.01) higher mammographic density than controls. Age terms, both linear (estimate = −0.9; P < 0.001) and quadratic (estimate = 0.05; P < 0.001), were significantly associated with the change in mammographic density, implying that percent density declined with age, but at a lower rate at older ages. A higher body mass index (estimate = −1.10; P < 0.001), higher number of children (estimate = −0.58; P < 0.01), and postmenopausal status (estimate = −0.88; P < 0.001) were all associated with lower percent density. Women who gave birth to their first child before the age of 25 years had a considerably lower percent density than did nulliparous women (estimate = −5.58; P < 0.001). The effect of age on the decline in percent density was similar for cases and controls: The interaction terms of age at mammography (linear or quadratic) and breast cancer status (linear, −0.05, P = 0.32; quadratic, 0.00, P = 0.84) were not statistically significant (Figure 2) . The likelihood ratio test, for testing the combination of the linear and quadratic interaction, also showed that the average change in percent density is not different between cases and controls (P = 0.56).
Similar to percent density, the initial absolute dense area was also higher in cases than controls (P < 0.001). Adjusting for nondense area instead of body mass index improved the fit of the model. Similar to percent density, the change in absolute dense area was not different for breast cancer cases and controls (likelihood ratio test: P = 0.49) (Figure 3) . Sensitivity analysis with exclusion of 93 digital mammograms or with exclusion of 286 mammograms taken within 1 year before breast cancer diagnosis did not show different results. Furthermore, an analysis restricted to the women with information available on age at menarche and family history indicated that including these variables in the models did not alter the results. We also used a logistic regression model to investigate the change in mammographic density between the initial and last available mammograms as a continuous variable in relation to breast cancer risk, including mammographic density at the initial mammogram. This did not lead to different conclusions (for each percentage point decrease in mammographic density, odds ratio = 1.01, 95% confidence interval: 0.99, 1.02). Women were also classified according to categories of percent density at the initial and last mammograms (<5%, 5%-25%, >25%-50%, and >50%): 47% of the women showed a decline; 49% stayed in the same category; and 4% showed an increase in percent density over an average period of 10 years. Although the numbers were very small, in Table 4 it can be observed that, generally, women in whom breast density decreased with one or more categories had a slightly lower risk of breast cancer than did those who stayed in the same category, although not statistically significant. This was observed more clearly for the dense area than for percent density. Those who increased in density by one or more categories seemed to have a slightly increased risk (statistically significant only for those increasing from the first to the second quartile of dense area). When change was categorized by the absolute difference in percent density (≥10% increase, no change, from ≥10% to <25% decrease, from ≥25% to <50% decrease, or ≥50% decrease) or absolute density (≥10 cm 2 increase, no change, from ≥10 cm 2 to <50 cm 2 decrease, ≥50 cm 2 decrease, or ≥100 cm 2 decrease), conclusions were similar.
DISCUSSION
In the current study, we found that, in both cases and controls, mammographic density declined with age, but at all mammographic examinations density was higher for cases than for controls. When mammographic density was examined as a continuous variable, the decline in mammographic density did not differ between breast cancer cases and controls. When we studied changes in categories of mammographic density between the first and last mammograms, overall, women who changed to a lower density category seemed to have a somewhat lower breast cancer risk, whereas women who changed to a higher density category seemed to have a somewhat higher breast cancer risk than did women who remained in the same category.
There is a vast amount of evidence that high mammographic density is associated with increased breast cancer risk, but the evidence on the effect of changes in mammographic density on breast cancer risk remains inconclusive. In agreement with other studies, we found that high mammographic density was associated with increased breast cancer risk (1, 2) and that the decline in mammographic density was approximately 11% in 10 years in both cases and controls (7, 8, 20) . Salminen et al. (9) , van Gils et al. (10) , and Kerlikowske et al. (11) did report an association between change in mammographic density and breast cancer risk when using categories. This is also in line with our findings on changes between categories, although we did find somewhat weaker results that were not statistically significant. In the largest study by Kerlikowske et al. (11) , women with a decline in mammographic density, defined as a change to a lower BI-RADS density scale (21), had a lower breast cancer risk. An increase in mammographic density was associated with higher breast cancer risk compared with women who were stable. However, the highest breast cancer risk was observed for women who had the highest mammographic density at the first mammogram, independently of whether mammographic density decreased thereafter (11) .
The discrepancy in findings between studies with continuous density measures and categorical measures may be explained by larger and smaller changes being averaged out in the first type of studies. This might indicate that changes have to be large to result in an effect on breast cancer risk. This is also in line with the findings of Cuzick et al. (22, 23) . They observed in a randomized clinical trial among women with increased breast cancer risk that tamoxifen use compared with placebo led to a decrease in mammographic density and that only the women with the largest decline in mammographic density (>10% in 12-18 months) had a decreased breast cancer risk. In this study, tamoxifen use caused large decreases in density only in women younger than 55 years, and particularly in those younger than 45 years.
As in many other countries, the breast cancer screening program in the Netherlands starts at the age of 50 years. Information on mammographic density before this age is therefore difficult to obtain. This is unfortunate because most of the change in mammographic density takes place around this age. As mentioned, the decline in mammographic density as result of tamoxifen use was greatest before 45 years (22, 23) . The study of Kerlikowske et al., on the other hand, who also included a large number of women younger than 50 years, found that changes in mammographic density after the age of 50 years had the greatest influence on breast cancer risk (11) . The most relevant period for the changes in mammographic density remains therefore uncertain.
The current study has several strengths as well as limitations. The main limitation is that the study population comprised only women of 50 years or older. Studying changes a Adjusted for age at first mammography, body mass index, parity (nulliparous, age at first delivery <25 years, age at first delivery ≥25 years), number of children, menopausal status (premenopausal, postmenopausal before first mammogram, postmenopausal between first and last mammograms), pill use (never pill use, pill use before first mammogram, pill use between first and last mammograms), hormone therapy use (never use, use before first mammogram, use between first and last mammograms), and follow-up time.
Changes in Mammographic Density 107 in mammographic density well before menopause was therefore not possible as is the case in most other studies using screening populations. Although the long follow-up time is a major strength of the current study, it has also inherent limitations. First, the techniques of the film-screen and the mammography systems changed in the last 20 years, which could have influenced the mammographic density assessment. Byrne (24) and Kelemen et al. (25) have raised some relevant issues. Newer mammographic techniques offer a higher dynamic range and contrast resolution that may make fibroglandular tissue appear less dense, leading to lower estimates of density in later than in earlier mammograms and, thus, to an overestimation of the decline in density. As both cases and controls have mammograms from the same time period, this is unlikely to have influenced our results. All mammograms were taken by the same screening organization that limited variation due to differences in mammography systems. Only a very small proportion of the mammograms used in this study were digital (n = 93, <1%), however, and sensitivity analysis showed no influence of excluding these mammograms. Another concern of Byrne (24) was that not all scanners capture the breast edge on the mammograms. We scanned all mammograms with the same dedicated mammography scanner (Canon CFS300 scanner; R2 Technology). This 12-bit scanner was able to make a clear distinction between the edge of the breast and the background.
The main strength of this study is the large study population with more than 500 cases and approximately 1,350 controls. All women had at least 3 and up to 11 mammograms. All mammograms were read by a single reader with a high intraclass correlation coefficient. The women included in this study were participants of a large cohort study of breast cancer screening participants. Data on breast cancer risk factors were collected long before breast cancer was diagnosed. As we had follow-up data on the risk factors of the women, we could also take changes in confounders into account.
In summary, women with higher mammographic density have higher breast cancer risk. The mean decline in mammographic density with age was not different between healthy women and those who developed breast cancer. Women with a large decline over time showed a somewhat lower risk than did the women with stable density, but the results were not statistically significant. It remains uncertain whether changes in mammographic density at a younger age would be of more clinical importance. There are several areas of research that could help to inform the relation between changes in density and breast cancer risk. Lobular involution has been suggested as one underlying physiological determinant of breast density (26, 27) , but it is unclear whether the changes in dense area or those in percent density are more representative of the extent of involution. Studies of biopsy tissue or autopsy studies in young women where direct measures of the extent of involution are related to density measures could help to increase understanding of the role of changes in mammographic density. Improved imaging techniques that give better and more reproducible estimates of the amounts of dense and nondense tissue (and not only their 2-dimensional areas) (28) (29) (30) may also help to solve the issue. In particular, the ongoing development of breast density measurement techniques on imaging methods that do not use x-rays and, therefore, can safely be applied to younger women is promising.
